Isocarboxazid appears to be a very workable hydrazine derivative for treating ambulatory depressions, and is of use as well in certain cases of schizophrenia. Relatively high doses are possible with relatively few side effects. The isocarboxazid for this study was supplied by Roche Laboratories (trademark, Marplan).Abstract Teaser